Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
KLF3
|
ENSG00000109787.8 | Kruppel like factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
KLF3 | hg19_v2_chr4_+_38665810_38665827 | -0.06 | 7.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_-_11370330 | 2.20 |
ENST00000241808.4
ENST00000435245.2 |
PRM2
|
protamine 2 |
chr20_+_3052264 | 2.12 |
ENST00000217386.2
|
OXT
|
oxytocin/neurophysin I prepropeptide |
chr20_+_2795626 | 1.96 |
ENST00000603872.1
ENST00000380589.4 |
C20orf141
|
chromosome 20 open reading frame 141 |
chr4_-_15964830 | 1.90 |
ENST00000259989.6
|
FGFBP2
|
fibroblast growth factor binding protein 2 |
chr16_+_1290694 | 1.88 |
ENST00000338844.3
|
TPSAB1
|
tryptase alpha/beta 1 |
chr4_-_82136114 | 1.73 |
ENST00000395578.1
ENST00000418486.2 |
PRKG2
|
protein kinase, cGMP-dependent, type II |
chrX_-_152486108 | 1.62 |
ENST00000356661.5
|
MAGEA1
|
melanoma antigen family A, 1 (directs expression of antigen MZ2-E) |
chr16_+_1306093 | 1.61 |
ENST00000211076.3
|
TPSD1
|
tryptase delta 1 |
chr20_+_2795609 | 1.60 |
ENST00000554164.1
ENST00000380593.4 |
TMEM239
TMEM239
|
transmembrane protein 239 CDNA FLJ26142 fis, clone TST04526; Transmembrane protein 239; Uncharacterized protein |
chrX_+_2670066 | 1.56 |
ENST00000381174.5
ENST00000419513.2 ENST00000426774.1 |
XG
|
Xg blood group |
chrX_+_142113704 | 1.52 |
ENST00000446864.1
ENST00000370504.3 |
SPANXN4
|
SPANX family, member N4 |
chr16_+_1290725 | 1.51 |
ENST00000461509.2
|
TPSAB1
|
tryptase alpha/beta 1 |
chr17_+_7323634 | 1.49 |
ENST00000323675.3
|
SPEM1
|
spermatid maturation 1 |
chr11_-_5248294 | 1.46 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr12_-_13256571 | 1.41 |
ENST00000545401.1
ENST00000432710.2 ENST00000351606.6 |
GSG1
|
germ cell associated 1 |
chr7_+_116165754 | 1.36 |
ENST00000405348.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr15_-_90233907 | 1.35 |
ENST00000561224.1
|
PEX11A
|
peroxisomal biogenesis factor 11 alpha |
chr6_-_35109080 | 1.34 |
ENST00000486638.1
ENST00000505400.1 ENST00000412155.2 ENST00000373979.2 ENST00000507706.1 ENST00000444780.2 ENST00000492680.2 |
TCP11
|
t-complex 11, testis-specific |
chr6_+_142622991 | 1.33 |
ENST00000230173.6
ENST00000367608.2 |
GPR126
|
G protein-coupled receptor 126 |
chr19_-_42927251 | 1.32 |
ENST00000597001.1
|
LIPE
|
lipase, hormone-sensitive |
chr12_-_13256593 | 1.32 |
ENST00000542415.1
ENST00000324458.8 |
GSG1
|
germ cell associated 1 |
chrX_+_2670153 | 1.29 |
ENST00000509484.2
|
XG
|
Xg blood group |
chr19_-_18902106 | 1.25 |
ENST00000542601.2
ENST00000425807.1 ENST00000222271.2 |
COMP
|
cartilage oligomeric matrix protein |
chr16_+_89696692 | 1.25 |
ENST00000261615.4
|
DPEP1
|
dipeptidase 1 (renal) |
chr16_+_66400533 | 1.20 |
ENST00000341529.3
|
CDH5
|
cadherin 5, type 2 (vascular endothelium) |
chr4_+_24797085 | 1.19 |
ENST00000382120.3
|
SOD3
|
superoxide dismutase 3, extracellular |
chr20_+_56136136 | 1.16 |
ENST00000319441.4
ENST00000543666.1 |
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble) |
chr21_+_19617140 | 1.14 |
ENST00000299295.2
ENST00000338326.3 |
CHODL
|
chondrolectin |
chr15_-_67351586 | 1.14 |
ENST00000558071.1
|
RP11-798K3.2
|
RP11-798K3.2 |
chr3_+_157261116 | 1.13 |
ENST00000468043.1
ENST00000459838.1 ENST00000461040.1 ENST00000449199.2 ENST00000426338.2 |
C3orf55
|
chromosome 3 open reading frame 55 |
chr18_+_6729725 | 1.13 |
ENST00000400091.2
ENST00000583410.1 ENST00000584387.1 |
ARHGAP28
|
Rho GTPase activating protein 28 |
chr11_+_60383204 | 1.13 |
ENST00000412599.1
ENST00000320202.4 |
LINC00301
|
long intergenic non-protein coding RNA 301 |
chr3_+_52828805 | 1.11 |
ENST00000416872.2
ENST00000449956.2 |
ITIH3
|
inter-alpha-trypsin inhibitor heavy chain 3 |
chrX_-_70326455 | 1.11 |
ENST00000374251.5
|
CXorf65
|
chromosome X open reading frame 65 |
chr12_+_7169887 | 1.10 |
ENST00000542978.1
|
C1S
|
complement component 1, s subcomponent |
chr2_+_21346789 | 1.09 |
ENST00000405799.1
|
TDRD15
|
tudor domain containing 15 |
chr19_+_33210645 | 1.08 |
ENST00000444215.2
|
TDRD12
|
tudor domain containing 12 |
chr17_+_41006095 | 1.08 |
ENST00000591562.1
ENST00000588033.1 |
AOC3
|
amine oxidase, copper containing 3 |
chr19_+_8429031 | 1.07 |
ENST00000301455.2
ENST00000541807.1 ENST00000393962.2 |
ANGPTL4
|
angiopoietin-like 4 |
chr12_-_8815404 | 1.06 |
ENST00000359478.2
ENST00000396549.2 |
MFAP5
|
microfibrillar associated protein 5 |
chr11_-_5531215 | 1.04 |
ENST00000311659.4
|
UBQLN3
|
ubiquilin 3 |
chrX_-_52260355 | 1.03 |
ENST00000375602.1
ENST00000399800.3 |
XAGE1A
|
X antigen family, member 1A |
chr1_+_212797789 | 1.03 |
ENST00000294829.3
|
FAM71A
|
family with sequence similarity 71, member A |
chrX_+_52511761 | 1.01 |
ENST00000399795.3
ENST00000375589.1 |
XAGE1C
|
X antigen family, member 1C |
chrX_-_133119670 | 1.00 |
ENST00000394299.2
|
GPC3
|
glypican 3 |
chr18_+_6729698 | 1.00 |
ENST00000383472.4
|
ARHGAP28
|
Rho GTPase activating protein 28 |
chr4_-_185820602 | 0.97 |
ENST00000515864.1
ENST00000507183.1 |
RP11-701P16.4
|
long intergenic non-protein coding RNA 1093 |
chr4_-_144940477 | 0.96 |
ENST00000513128.1
ENST00000429670.2 ENST00000502664.1 |
GYPB
|
glycophorin B (MNS blood group) |
chr7_+_73245193 | 0.95 |
ENST00000340958.2
|
CLDN4
|
claudin 4 |
chr12_-_53045948 | 0.95 |
ENST00000309680.3
|
KRT2
|
keratin 2 |
chr5_-_138842286 | 0.95 |
ENST00000515823.1
|
ECSCR
|
endothelial cell surface expressed chemotaxis and apoptosis regulator |
chr15_-_62457480 | 0.94 |
ENST00000380392.3
|
C2CD4B
|
C2 calcium-dependent domain containing 4B |
chr9_-_34729457 | 0.93 |
ENST00000378788.3
|
FAM205A
|
family with sequence similarity 205, member A |
chr13_+_102104952 | 0.92 |
ENST00000376180.3
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains) |
chr19_+_39897943 | 0.92 |
ENST00000600033.1
|
ZFP36
|
ZFP36 ring finger protein |
chr7_-_99573677 | 0.90 |
ENST00000292401.4
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
chr11_-_57158109 | 0.88 |
ENST00000525955.1
ENST00000533605.1 ENST00000311862.5 |
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) |
chr12_-_23737534 | 0.88 |
ENST00000396007.2
|
SOX5
|
SRY (sex determining region Y)-box 5 |
chr9_-_34710066 | 0.86 |
ENST00000378792.1
ENST00000259607.2 |
CCL21
|
chemokine (C-C motif) ligand 21 |
chr15_+_40643227 | 0.86 |
ENST00000448599.2
|
PHGR1
|
proline/histidine/glycine-rich 1 |
chr1_-_110306562 | 0.85 |
ENST00000369805.3
|
EPS8L3
|
EPS8-like 3 |
chr2_-_20425158 | 0.85 |
ENST00000381150.1
|
SDC1
|
syndecan 1 |
chr6_+_44184653 | 0.85 |
ENST00000573382.2
ENST00000576476.1 |
RP1-302G2.5
|
RP1-302G2.5 |
chr4_-_155511887 | 0.84 |
ENST00000302053.3
ENST00000403106.3 |
FGA
|
fibrinogen alpha chain |
chr11_-_5531159 | 0.83 |
ENST00000445998.1
|
UBQLN3
|
ubiquilin 3 |
chr6_-_35109145 | 0.83 |
ENST00000373974.4
ENST00000244645.3 |
TCP11
|
t-complex 11, testis-specific |
chr19_-_375970 | 0.83 |
ENST00000346878.2
|
THEG
|
theg spermatid protein |
chr6_+_144471643 | 0.82 |
ENST00000367568.4
|
STX11
|
syntaxin 11 |
chrX_+_52238810 | 0.82 |
ENST00000437949.2
ENST00000375616.1 |
XAGE1B
|
X antigen family, member 1B |
chr17_+_38599693 | 0.81 |
ENST00000542955.1
ENST00000269593.4 |
IGFBP4
|
insulin-like growth factor binding protein 4 |
chrX_-_71526999 | 0.80 |
ENST00000453707.2
ENST00000373619.3 |
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 |
chrX_-_52533139 | 0.80 |
ENST00000374959.3
|
XAGE1D
|
X antigen family, member 1D |
chrX_-_52546189 | 0.79 |
ENST00000375570.1
ENST00000429372.2 |
XAGE1E
|
X antigen family, member 1E |
chr3_-_124560257 | 0.79 |
ENST00000496703.1
|
ITGB5
|
integrin, beta 5 |
chr17_+_34312621 | 0.78 |
ENST00000591669.1
|
CTB-186H2.3
|
Uncharacterized protein |
chr17_+_79989500 | 0.78 |
ENST00000306897.4
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
chrX_+_52511925 | 0.77 |
ENST00000375588.1
|
XAGE1C
|
X antigen family, member 1C |
chr3_+_140396881 | 0.77 |
ENST00000286349.3
|
TRIM42
|
tripartite motif containing 42 |
chrX_-_52260199 | 0.77 |
ENST00000375600.1
|
XAGE1A
|
X antigen family, member 1A |
chr11_+_1860832 | 0.76 |
ENST00000252898.7
|
TNNI2
|
troponin I type 2 (skeletal, fast) |
chrX_-_153599578 | 0.76 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
chr14_+_32414059 | 0.75 |
ENST00000553330.1
|
RP11-187E13.1
|
Uncharacterized protein |
chrX_+_140096761 | 0.75 |
ENST00000370530.1
|
SPANXB1
|
SPANX family, member B1 |
chr2_+_217498105 | 0.75 |
ENST00000233809.4
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa |
chr15_-_76005170 | 0.75 |
ENST00000308508.5
|
CSPG4
|
chondroitin sulfate proteoglycan 4 |
chr4_+_119810134 | 0.75 |
ENST00000434046.2
|
SYNPO2
|
synaptopodin 2 |
chr20_-_590944 | 0.75 |
ENST00000246080.3
|
TCF15
|
transcription factor 15 (basic helix-loop-helix) |
chr1_-_154458520 | 0.75 |
ENST00000486773.1
|
SHE
|
Src homology 2 domain containing E |
chr6_+_126661253 | 0.74 |
ENST00000368326.1
ENST00000368325.1 ENST00000368328.4 |
CENPW
|
centromere protein W |
chrX_-_52533295 | 0.74 |
ENST00000375578.1
ENST00000396497.3 |
XAGE1D
|
X antigen family, member 1D |
chr17_-_48278983 | 0.74 |
ENST00000225964.5
|
COL1A1
|
collagen, type I, alpha 1 |
chr4_+_119809984 | 0.74 |
ENST00000307142.4
ENST00000448416.2 ENST00000429713.2 |
SYNPO2
|
synaptopodin 2 |
chr20_+_43803517 | 0.73 |
ENST00000243924.3
|
PI3
|
peptidase inhibitor 3, skin-derived |
chr14_+_63671577 | 0.72 |
ENST00000555125.1
|
RHOJ
|
ras homolog family member J |
chr11_-_65793948 | 0.72 |
ENST00000312106.5
|
CATSPER1
|
cation channel, sperm associated 1 |
chr1_+_41707996 | 0.72 |
ENST00000425554.1
|
RP11-399E6.1
|
RP11-399E6.1 |
chr12_-_57634475 | 0.72 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
chr18_+_42277095 | 0.71 |
ENST00000591940.1
|
SETBP1
|
SET binding protein 1 |
chr6_+_35744367 | 0.71 |
ENST00000360454.2
ENST00000403376.3 |
CLPSL2
|
colipase-like 2 |
chr1_-_22215192 | 0.71 |
ENST00000374673.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
chrX_-_47489244 | 0.70 |
ENST00000469388.1
ENST00000396992.3 ENST00000377005.2 |
CFP
|
complement factor properdin |
chr20_+_59654146 | 0.70 |
ENST00000441660.1
|
RP5-827L5.1
|
RP5-827L5.1 |
chr19_+_39279838 | 0.70 |
ENST00000314980.4
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B |
chr1_+_159409512 | 0.70 |
ENST00000423932.3
|
OR10J1
|
olfactory receptor, family 10, subfamily J, member 1 |
chr2_+_177502438 | 0.70 |
ENST00000443670.1
|
AC017048.4
|
long intergenic non-protein coding RNA 1117 |
chrX_-_52546033 | 0.70 |
ENST00000375567.3
|
XAGE1E
|
X antigen family, member 1E |
chr12_+_12878829 | 0.69 |
ENST00000326765.6
|
APOLD1
|
apolipoprotein L domain containing 1 |
chr20_+_12930980 | 0.69 |
ENST00000432244.1
|
RP11-157E14.1
|
RP11-157E14.1 |
chr22_-_21387127 | 0.69 |
ENST00000426145.1
|
SLC7A4
|
solute carrier family 7, member 4 |
chr2_-_20424844 | 0.68 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
chr12_-_7244469 | 0.68 |
ENST00000538050.1
ENST00000536053.2 |
C1R
|
complement component 1, r subcomponent |
chr2_+_238165734 | 0.68 |
ENST00000445534.2
|
AC112715.2
|
Uncharacterized protein |
chrX_-_151938171 | 0.67 |
ENST00000393902.3
ENST00000417212.1 ENST00000370278.3 |
MAGEA3
|
melanoma antigen family A, 3 |
chr16_+_31483374 | 0.67 |
ENST00000394863.3
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
chr3_-_120169828 | 0.67 |
ENST00000424703.2
ENST00000469005.1 |
FSTL1
|
follistatin-like 1 |
chr17_+_6926339 | 0.67 |
ENST00000293805.5
|
BCL6B
|
B-cell CLL/lymphoma 6, member B |
chr16_+_31483451 | 0.66 |
ENST00000565360.1
ENST00000361773.3 |
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
chr12_-_13248562 | 0.66 |
ENST00000457134.2
ENST00000537302.1 |
GSG1
|
germ cell associated 1 |
chr11_+_844067 | 0.66 |
ENST00000397406.1
ENST00000409543.2 ENST00000525201.1 |
TSPAN4
|
tetraspanin 4 |
chr11_+_57365150 | 0.66 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr16_+_89238149 | 0.65 |
ENST00000289746.2
|
CDH15
|
cadherin 15, type 1, M-cadherin (myotubule) |
chr4_+_123300664 | 0.65 |
ENST00000388725.2
|
ADAD1
|
adenosine deaminase domain containing 1 (testis-specific) |
chr17_-_39928106 | 0.65 |
ENST00000540235.1
|
JUP
|
junction plakoglobin |
chrX_-_103499602 | 0.65 |
ENST00000372588.4
|
ESX1
|
ESX homeobox 1 |
chr14_-_94970559 | 0.64 |
ENST00000556881.1
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
chr8_-_23712312 | 0.64 |
ENST00000290271.2
|
STC1
|
stanniocalcin 1 |
chr19_-_14016877 | 0.63 |
ENST00000454313.1
ENST00000591586.1 ENST00000346736.2 |
C19orf57
|
chromosome 19 open reading frame 57 |
chr15_+_59397298 | 0.63 |
ENST00000559622.1
|
CCNB2
|
cyclin B2 |
chr8_+_22102611 | 0.63 |
ENST00000306433.4
|
POLR3D
|
polymerase (RNA) III (DNA directed) polypeptide D, 44kDa |
chr10_+_71211212 | 0.63 |
ENST00000373290.2
|
TSPAN15
|
tetraspanin 15 |
chr8_-_13134045 | 0.62 |
ENST00000512044.2
|
DLC1
|
deleted in liver cancer 1 |
chr4_-_75719896 | 0.62 |
ENST00000395743.3
|
BTC
|
betacellulin |
chr17_+_6926381 | 0.62 |
ENST00000576705.1
|
BCL6B
|
B-cell CLL/lymphoma 6, member B |
chr15_+_88795953 | 0.62 |
ENST00000569588.1
|
NTRK3-AS1
|
NTRK3 antisense RNA 1 |
chr1_-_120311517 | 0.62 |
ENST00000369406.3
ENST00000544913.2 |
HMGCS2
|
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
chr15_-_101084446 | 0.62 |
ENST00000538112.2
ENST00000559639.1 ENST00000558884.2 |
CERS3
|
ceramide synthase 3 |
chr15_-_101084547 | 0.62 |
ENST00000394113.1
|
CERS3
|
ceramide synthase 3 |
chr5_+_135385202 | 0.60 |
ENST00000514554.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chrX_-_71526813 | 0.60 |
ENST00000246139.5
|
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 |
chr13_+_31480843 | 0.59 |
ENST00000428944.1
|
MEDAG
|
mesenteric estrogen-dependent adipogenesis |
chr16_-_86383240 | 0.59 |
ENST00000595169.1
ENST00000598994.1 ENST00000599619.1 ENST00000599664.1 |
LINC00917
|
long intergenic non-protein coding RNA 917 |
chr15_-_90358564 | 0.59 |
ENST00000559874.1
|
ANPEP
|
alanyl (membrane) aminopeptidase |
chrX_+_153813407 | 0.59 |
ENST00000443287.2
ENST00000333128.3 |
CTAG1A
|
cancer/testis antigen 1A |
chr18_-_61329118 | 0.57 |
ENST00000332821.8
ENST00000283752.5 |
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3 |
chr1_-_155112883 | 0.57 |
ENST00000368399.1
ENST00000368400.4 ENST00000341298.3 |
DPM3
|
dolichyl-phosphate mannosyltransferase polypeptide 3 |
chr1_+_152483278 | 0.57 |
ENST00000334269.2
|
LCE5A
|
late cornified envelope 5A |
chr4_-_681114 | 0.56 |
ENST00000503156.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
chr19_+_35630344 | 0.56 |
ENST00000455515.2
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr19_-_35626104 | 0.56 |
ENST00000310123.3
ENST00000392225.3 |
LGI4
|
leucine-rich repeat LGI family, member 4 |
chr19_-_51334769 | 0.56 |
ENST00000596931.1
ENST00000416184.1 ENST00000301421.2 ENST00000598239.1 |
KLK15
|
kallikrein-related peptidase 15 |
chr21_-_40032581 | 0.56 |
ENST00000398919.2
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
chr19_+_42811093 | 0.56 |
ENST00000595750.1
|
PRR19
|
proline rich 19 |
chr16_-_8962853 | 0.55 |
ENST00000565287.1
ENST00000311052.5 |
CARHSP1
|
calcium regulated heat stable protein 1, 24kDa |
chr7_-_4923259 | 0.55 |
ENST00000536091.1
|
RADIL
|
Ras association and DIL domains |
chr12_-_21927736 | 0.55 |
ENST00000240662.2
|
KCNJ8
|
potassium inwardly-rectifying channel, subfamily J, member 8 |
chr8_-_144699628 | 0.55 |
ENST00000529048.1
ENST00000529064.1 |
TSTA3
|
tissue specific transplantation antigen P35B |
chr17_+_39968926 | 0.55 |
ENST00000585664.1
ENST00000585922.1 ENST00000429461.1 |
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr21_-_38445470 | 0.55 |
ENST00000399098.1
|
PIGP
|
phosphatidylinositol glycan anchor biosynthesis, class P |
chr7_-_148580563 | 0.55 |
ENST00000476773.1
|
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
chr1_-_242162375 | 0.55 |
ENST00000357246.3
|
MAP1LC3C
|
microtubule-associated protein 1 light chain 3 gamma |
chr17_+_34087888 | 0.54 |
ENST00000586491.1
ENST00000588628.1 ENST00000285023.4 |
C17orf50
|
chromosome 17 open reading frame 50 |
chr3_+_57094469 | 0.54 |
ENST00000334325.1
|
SPATA12
|
spermatogenesis associated 12 |
chr11_+_844406 | 0.54 |
ENST00000397404.1
|
TSPAN4
|
tetraspanin 4 |
chr3_+_42892458 | 0.54 |
ENST00000494619.1
|
ACKR2
|
atypical chemokine receptor 2 |
chr7_+_45197383 | 0.54 |
ENST00000242249.4
ENST00000496212.1 ENST00000481345.1 |
RAMP3
|
receptor (G protein-coupled) activity modifying protein 3 |
chr1_+_16083098 | 0.54 |
ENST00000496928.2
ENST00000508310.1 |
FBLIM1
|
filamin binding LIM protein 1 |
chr1_+_27113963 | 0.54 |
ENST00000430292.1
|
PIGV
|
phosphatidylinositol glycan anchor biosynthesis, class V |
chr6_-_36304660 | 0.53 |
ENST00000437635.2
|
C6orf222
|
chromosome 6 open reading frame 222 |
chr9_+_35792151 | 0.53 |
ENST00000342694.2
|
NPR2
|
natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
chr22_+_38071615 | 0.53 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
chr2_-_177502659 | 0.53 |
ENST00000295549.4
|
AC017048.3
|
long intergenic non-protein coding RNA 1116 |
chr15_-_74659978 | 0.53 |
ENST00000541301.1
ENST00000416978.1 ENST00000268053.6 |
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1 |
chr1_+_16083123 | 0.53 |
ENST00000510393.1
ENST00000430076.1 |
FBLIM1
|
filamin binding LIM protein 1 |
chr12_+_3068466 | 0.53 |
ENST00000358409.2
|
TEAD4
|
TEA domain family member 4 |
chr13_+_102104980 | 0.52 |
ENST00000545560.2
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains) |
chr19_-_16008880 | 0.52 |
ENST00000011989.7
ENST00000221700.6 |
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2 |
chr12_+_7072354 | 0.52 |
ENST00000537269.1
|
U47924.27
|
U47924.27 |
chr11_-_68780701 | 0.52 |
ENST00000320913.6
|
MRGPRF
|
MAS-related GPR, member F |
chr22_-_20138302 | 0.52 |
ENST00000540078.1
ENST00000439765.2 |
AC006547.14
|
uncharacterized protein LOC388849 |
chrX_+_30260054 | 0.52 |
ENST00000378982.2
|
MAGEB4
|
melanoma antigen family B, 4 |
chr13_-_111214015 | 0.52 |
ENST00000267328.3
|
RAB20
|
RAB20, member RAS oncogene family |
chr8_+_22414182 | 0.52 |
ENST00000524057.1
|
SORBS3
|
sorbin and SH3 domain containing 3 |
chr6_+_138725343 | 0.51 |
ENST00000607197.1
ENST00000367697.3 |
HEBP2
|
heme binding protein 2 |
chr16_-_1843720 | 0.51 |
ENST00000415638.3
ENST00000215539.3 |
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit |
chr1_+_6511651 | 0.51 |
ENST00000434576.1
|
ESPN
|
espin |
chr11_-_117103208 | 0.51 |
ENST00000320934.3
ENST00000530269.1 |
PCSK7
|
proprotein convertase subtilisin/kexin type 7 |
chr18_-_14543145 | 0.51 |
ENST00000358970.5
|
POTEC
|
POTE ankyrin domain family, member C |
chr7_+_130020932 | 0.50 |
ENST00000484324.1
|
CPA1
|
carboxypeptidase A1 (pancreatic) |
chr12_-_55042140 | 0.50 |
ENST00000293371.6
ENST00000456047.2 |
DCD
|
dermcidin |
chr14_-_21566731 | 0.50 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
chr14_+_63671105 | 0.49 |
ENST00000316754.3
|
RHOJ
|
ras homolog family member J |
chr19_+_41107249 | 0.49 |
ENST00000396819.3
|
LTBP4
|
latent transforming growth factor beta binding protein 4 |
chr20_+_43029911 | 0.48 |
ENST00000443598.2
ENST00000316099.4 ENST00000415691.2 |
HNF4A
|
hepatocyte nuclear factor 4, alpha |
chr3_-_58196688 | 0.48 |
ENST00000486455.1
|
DNASE1L3
|
deoxyribonuclease I-like 3 |
chr17_-_63822563 | 0.48 |
ENST00000317442.8
|
CEP112
|
centrosomal protein 112kDa |
chr19_+_1941117 | 0.48 |
ENST00000255641.8
|
CSNK1G2
|
casein kinase 1, gamma 2 |
chr11_-_114466471 | 0.48 |
ENST00000424261.2
|
NXPE4
|
neurexophilin and PC-esterase domain family, member 4 |
chr8_+_22428457 | 0.48 |
ENST00000517962.1
|
SORBS3
|
sorbin and SH3 domain containing 3 |
chr1_-_57045228 | 0.48 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr12_-_10151773 | 0.47 |
ENST00000298527.6
ENST00000348658.4 |
CLEC1B
|
C-type lectin domain family 1, member B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.7 | 2.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) positive regulation of female receptivity(GO:0045925) |
0.6 | 1.9 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.5 | 2.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.5 | 1.5 | GO:0048627 | myoblast development(GO:0048627) |
0.5 | 1.4 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.4 | 1.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.4 | 1.5 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.4 | 1.1 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.3 | 1.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.3 | 2.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 0.9 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.3 | 1.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 0.8 | GO:1903717 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
0.3 | 0.8 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.2 | 1.9 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.2 | 0.7 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.2 | 0.7 | GO:0044691 | tooth eruption(GO:0044691) |
0.2 | 0.9 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.2 | 0.5 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.2 | 0.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.5 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 0.8 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.1 | 1.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.6 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 1.0 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.6 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.1 | 0.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.5 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.1 | 0.4 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.1 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.6 | GO:1904141 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.1 | 0.4 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.1 | 1.0 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.1 | 0.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) renal water absorption(GO:0070295) |
0.1 | 0.3 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 0.3 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.1 | 0.4 | GO:0052361 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.1 | 1.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.7 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.5 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.6 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.3 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.1 | 0.6 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 1.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 1.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 1.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.6 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 1.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.1 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.1 | 0.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.2 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.4 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.1 | 0.1 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.1 | 0.5 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 1.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.3 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.9 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 0.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 0.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.3 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.1 | 0.4 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.1 | 0.7 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.1 | 1.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 0.3 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.1 | 0.3 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.1 | 0.1 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
0.1 | 0.2 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.1 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.3 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.1 | 1.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.6 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.4 | GO:1902231 | positive regulation of keratinocyte apoptotic process(GO:1902174) positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.2 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 0.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.1 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.0 | 0.8 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.0 | 1.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 1.2 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0045575 | basophil activation(GO:0045575) |
0.0 | 0.4 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.2 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) response to thyrotropin-releasing hormone(GO:1905225) |
0.0 | 2.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 1.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.3 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.0 | 1.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.2 | GO:0003095 | pressure natriuresis(GO:0003095) vitamin E metabolic process(GO:0042360) |
0.0 | 0.3 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.0 | 1.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.1 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.4 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.0 | 0.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.3 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.0 | 0.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.3 | GO:0070885 | positive regulation of sodium:proton antiporter activity(GO:0032417) negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.4 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.0 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 1.0 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.8 | GO:0010226 | response to lithium ion(GO:0010226) |
0.0 | 0.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.7 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.7 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.2 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.1 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.0 | 0.1 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.0 | 0.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.7 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
0.0 | 0.1 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.0 | 0.1 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.0 | 0.5 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.1 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.0 | 0.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.0 | GO:0070054 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.0 | 0.2 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.0 | 0.1 | GO:1903939 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of TORC2 signaling(GO:1903939) |
0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.9 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.1 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 0.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.1 | GO:0044107 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.0 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.3 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.9 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.1 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.0 | 0.1 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.0 | 1.8 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.9 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 3.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.1 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.0 | 1.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.0 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.5 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.0 | 0.8 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:0070945 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 1.1 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 1.1 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 1.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.0 | 0.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 1.3 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.0 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.0 | 0.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.4 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.0 | 0.2 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.0 | 0.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.3 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.0 | 0.0 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.0 | 0.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.0 | 0.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 1.2 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.7 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.2 | 0.8 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.2 | 0.8 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 1.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 0.6 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
0.1 | 2.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.4 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 0.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.6 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.1 | 0.5 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.7 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 1.8 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 2.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 0.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 1.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.8 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.0 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 4.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.6 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 1.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 1.9 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.2 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 2.0 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 1.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 3.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 1.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 1.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.2 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 1.6 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.4 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.4 | 1.3 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.4 | 1.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.3 | 1.7 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.3 | 1.1 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.3 | 1.0 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.2 | 1.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.8 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.2 | 0.6 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
0.2 | 0.6 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.2 | 0.5 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
0.2 | 0.5 | GO:0030395 | lactose binding(GO:0030395) |
0.2 | 0.5 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.2 | 0.6 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.1 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 2.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.7 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 1.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 1.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.4 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.4 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.1 | 1.3 | GO:0034235 | GPI anchor binding(GO:0034235) metallodipeptidase activity(GO:0070573) |
0.1 | 1.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 1.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 1.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.3 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
0.1 | 0.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 3.0 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.6 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.2 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 1.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.1 | 0.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 2.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 1.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.2 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 3.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.9 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.5 | GO:0047035 | alcohol dehydrogenase (NAD) activity(GO:0004022) testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.0 | 0.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.0 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.0 | 0.1 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.0 | 0.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 1.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.1 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.0 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.2 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.6 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 7.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.7 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.0 | 0.1 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.0 | 0.8 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.6 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 0.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 1.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 2.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.0 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 1.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.2 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.0 | 0.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 1.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 1.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 5.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 2.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 3.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 2.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 2.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 2.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 1.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 1.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 2.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 3.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.8 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.2 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.0 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 2.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |